172 related articles for article (PubMed ID: 29637599)
1. Metastatic tumor cells detection and anti-metastatic potential with vesicular stomatitis virus in immunocompetent murine model of osteosarcoma.
Johan MP; Kubo T; Furuta T; Sakuda T; Sakaguchi T; Nakanishi M; Ochi M; Adachi N
J Orthop Res; 2018 Sep; 36(9):2562-2569. PubMed ID: 29637599
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-12 expression enhances vesicular stomatitis virus oncolytic therapy in murine squamous cell carcinoma.
Shin EJ; Wanna GB; Choi B; Aguila D; Ebert O; Genden EM; Woo SL
Laryngoscope; 2007 Feb; 117(2):210-4. PubMed ID: 17204993
[TBL] [Abstract][Full Text] [Related]
3. Novel Near-Infrared Fluorescence-Guided Surgery With Vesicular Stomatitis Virus for Complete Surgical Resection of Osteosarcomas in Mice.
Sakuda T; Kubo T; Johan MP; Furuta T; Sakaguchi T; Nakanishi M; Ochi M; Adachi N
J Orthop Res; 2019 May; 37(5):1192-1201. PubMed ID: 30839125
[TBL] [Abstract][Full Text] [Related]
4. Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice.
Ebert O; Harbaran S; Shinozaki K; Woo SL
Cancer Gene Ther; 2005 Apr; 12(4):350-8. PubMed ID: 15565179
[TBL] [Abstract][Full Text] [Related]
5. The potential of recombinant vesicular stomatitis virus-mediated virotherapy against metastatic colon cancer.
Yamaki M; Shinozaki K; Sakaguchi T; Meseck M; Ebert O; Ohdan H; Woo SL
Int J Mol Med; 2013 Feb; 31(2):299-306. PubMed ID: 23232984
[TBL] [Abstract][Full Text] [Related]
6. Oncolysis of hepatic metastasis of colorectal cancer by recombinant vesicular stomatitis virus in immune-competent mice.
Huang TG; Ebert O; Shinozaki K; García-Sastre A; Woo SL
Mol Ther; 2003 Sep; 8(3):434-40. PubMed ID: 12946316
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic vesicular stomatitis virus administered by isolated limb perfusion suppresses osteosarcoma growth.
Kubo T; Shimose S; Matsuo T; Fujimori J; Sakaguchi T; Yamaki M; Shinozaki K; Woo SL; Ochi M
J Orthop Res; 2011 May; 29(5):795-800. PubMed ID: 21437961
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic Effect of a Recombinant Vesicular Stomatitis Virus Encoding a Tumor-suppressor MicroRNA in an Osteosarcoma Mouse Model.
Sakuda T; Kubo T; Johan MP; Furuta T; Sakaguchi T; Adachi N
Anticancer Res; 2023 Mar; 43(3):1185-1191. PubMed ID: 36854523
[TBL] [Abstract][Full Text] [Related]
9. Enhanced oncolytic activity of vesicular stomatitis virus encoding SV5-F protein against prostate cancer.
Chang G; Xu S; Watanabe M; Jayakar HR; Whitt MA; Gingrich JR
J Urol; 2010 Apr; 183(4):1611-8. PubMed ID: 20172545
[TBL] [Abstract][Full Text] [Related]
10. Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells.
Seegers SL; Frasier C; Greene S; Nesmelova IV; Grdzelishvili VZ
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694943
[TBL] [Abstract][Full Text] [Related]
11. Development of an Oncolytic Recombinant Vesicular Stomatitis Virus Encoding a Tumor-suppressor MicroRNA.
Sakuda T; Kubo T; Johan MP; Furuta T; Sakaguchi T; Adachi N
Anticancer Res; 2020 Nov; 40(11):6319-6325. PubMed ID: 33109569
[TBL] [Abstract][Full Text] [Related]
12. The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma.
Kimpel J; Urbiola C; Koske I; Tober R; Banki Z; Wollmann G; von Laer D
Viruses; 2018 Mar; 10(3):. PubMed ID: 29498639
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic vesicular stomatitis virus for treatment of orthotopic hepatocellular carcinoma in immune-competent rats.
Ebert O; Shinozaki K; Huang TG; Savontaus MJ; García-Sastre A; Woo SL
Cancer Res; 2003 Jul; 63(13):3605-11. PubMed ID: 12839948
[TBL] [Abstract][Full Text] [Related]
14. Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer.
Patel MR; Jacobson BA; Ji Y; Drees J; Tang S; Xiong K; Wang H; Prigge JE; Dash AS; Kratzke AK; Mesev E; Etchison R; Federspiel MJ; Russell SJ; Kratzke RA
Oncotarget; 2015 Oct; 6(32):33165-77. PubMed ID: 26431376
[TBL] [Abstract][Full Text] [Related]
15. Synergistic VSV Virotherapy and Carbon Nanotube Photothermal Therapy for Osteosarcoma in Murine Models.
Sakuda T; Oda A; Furuta T; Johan MP; Sakaguchi T; Adachi N
Anticancer Res; 2024 Jan; 44(1):99-105. PubMed ID: 38159977
[TBL] [Abstract][Full Text] [Related]
16. Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.
Falls T; Roy DG; Bell JC; Bourgeois-Daigneault MC
ILAR J; 2016; 57(1):73-85. PubMed ID: 27034397
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivo.
Yarde DN; Nace RA; Russell SJ
Exp Hematol; 2013 Dec; 41(12):1038-49. PubMed ID: 24067362
[TBL] [Abstract][Full Text] [Related]
18. Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity.
Obuchi M; Fernandez M; Barber GN
J Virol; 2003 Aug; 77(16):8843-56. PubMed ID: 12885903
[TBL] [Abstract][Full Text] [Related]
19. Combined VSV oncolytic virus and chemotherapy for squamous cell carcinoma.
Sung CK; Choi B; Wanna G; Genden EM; Woo SL; Shin EJ
Laryngoscope; 2008 Feb; 118(2):237-42. PubMed ID: 18043494
[TBL] [Abstract][Full Text] [Related]
20. Treatment of multi-focal colorectal carcinoma metastatic to the liver of immune-competent and syngeneic rats by hepatic artery infusion of oncolytic vesicular stomatitis virus.
Shinozaki K; Ebert O; Woo SL
Int J Cancer; 2005 Apr; 114(4):659-64. PubMed ID: 15609320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
